BACKGROUND Bronchiolitis obliterans syndrome (BOS) is a leading cause of chronic graft-vs-host disease (cGvHD) and is associated with mortality after allogeneic hematopoietic stem cell transplantation (alloHSCT). The nitrogen multiple breath washout test (N2-MBW) measures ventilation inhomogeneity, a biomarker of central and peripheral airway obstruction. The aim of this study was to examine ventilation inhomogeneity according to cGvHD score and histologically defined bronchiolitis obliterans (BO). METHODS This single-center prospective cross-sectional study included 225 adults (mean age, 52.8 years; median, 5.4 years (interquartile range, 2.0-11 years) after alloHSCT). Outcomes were global (lung clearance index [LCI]) and acinar v...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic he...
Bronchiolitis obliterans syndrome (BOS) compromises lung transplant outcomes and is characterised by...
Bronchiolitis obliterans (BO) following allogeneic haematopoietic stem cell transplantation (HSCT) a...
Forced expiratory volume in 1 second (FEV1 ) from spirometry is the most commonly used parameter to ...
Forced expiratory volume in 1 second (FEV ) from spirometry is the most commonly used parameter to d...
The work presented in this thesis explores the potential of multiple breath nitrogen washout (MBNW) ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Bronchiolitis obliterans (BO) is a serious pulmonary complication after allogeneic hematopoietic ste...
AbstractNoninfectious pulmonary syndromes (NIPS) frequently complicate allogeneic stem cell transpla...
The management of bronchiolitis obliterans syndrome (BOS) after hematopoietic cell transplantation p...
AbstractThe management of bronchiolitis obliterans syndrome (BOS) after hematopoietic cell transplan...
SummaryRationaleBronchiolitis obliterans syndrome (BOS) is a late, non-infectious pulmonary complica...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic he...
Bronchiolitis obliterans syndrome (BOS) compromises lung transplant outcomes and is characterised by...
Bronchiolitis obliterans (BO) following allogeneic haematopoietic stem cell transplantation (HSCT) a...
Forced expiratory volume in 1 second (FEV1 ) from spirometry is the most commonly used parameter to ...
Forced expiratory volume in 1 second (FEV ) from spirometry is the most commonly used parameter to d...
The work presented in this thesis explores the potential of multiple breath nitrogen washout (MBNW) ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Bronchiolitis obliterans (BO) is a serious pulmonary complication after allogeneic hematopoietic ste...
AbstractNoninfectious pulmonary syndromes (NIPS) frequently complicate allogeneic stem cell transpla...
The management of bronchiolitis obliterans syndrome (BOS) after hematopoietic cell transplantation p...
AbstractThe management of bronchiolitis obliterans syndrome (BOS) after hematopoietic cell transplan...
SummaryRationaleBronchiolitis obliterans syndrome (BOS) is a late, non-infectious pulmonary complica...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic he...
Bronchiolitis obliterans syndrome (BOS) compromises lung transplant outcomes and is characterised by...